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Introduction
Major obstacles faced by neuroscientists
in attempting to unravel the complexity of
brain function include both the heteroge-
neity of brain tissue (with a multitude of
cell types present in vivo) and the high
speed of brain information processing
(with behaviorally relevant millisecond-
scale electrical activity patterns). To ad-
dress different aspects of these technical
constraints, genetically targetable neural
modulation tools have been developed by
a number of groups (Zemelman et al.,
2002; Banghart et al., 2004; Karpova et al.,
2005; Lima and Miesenbock, 2005;
Thompson et al., 2005; Chambers et al.,
2006; Tan et al., 2006; Gorostiza et al.,
2007; Lerchner et al., 2007; Szobota et
al., 2007). One approach recently brought
to neurobiology, combining both high
speed and genetic targeting, is based on a
family of fast light-responsive microbial
opsins including halorhodopsins (e.g.,
NpHR) and channelrhodopsins (e.g.,
ChR2) (for review, see Zhang et al.,
2007b). Thesemicrobial opsins are single-
component transmembrane conductance
regulators encompassing light sensitivity
and fast membrane potential control
within a single open reading frame, which
can be used to achieve fast bidirectional
control of specific cell types even in freely
moving animals (Adamantidis et al., 2007;
Zhang et al., 2007a). Although the basic
functioning of these tools has been re-
viewed previously (Zhang et al., 2007b),
here we describe a collection of targeting
and readout strategies designed for rapid
and flexible application of the microbial
opsin system, and provide pointers to the
relevant literature. Combinations of these
multiple levels of targeting and readout
define an evolving toolbox that may open




Although it had been known that micro-
bial opsins can control membrane poten-
tial in their native settings and various re-
duced systems (e.g., Ehrlich et al., 1984;
Kalaidzidis et al., 1998; Nagel et al., 2002,
2003), the surprising ability of these pro-
teins when heterologously expressed to
precisely control neurons and the tech-
nology for applying these tools in freely
behaving animals have been demon-
strated only over the past two years (for
review, see Zhang et al., 2007b). ChR2was
the first microbial opsin brought to neu-
robiology, where it was initially found in
hippocampal neurons that ChR2-
expressing neurons can fire blue light-
triggered action potentials with millisec-
ond precision, as a result of depolarizing
cation flux, without addition of chemical
cofactors (Boyden et al., 2005). This ap-
proach has since proven versatile across a
variety of preparations (Li et al., 2005; Na-
gel et al., 2005; Bi et al., 2006;Deisseroth et
al., 2006; Ishizuka et al., 2006; Schroll et
al., 2006; Zhang et al., 2006, 2007a; Aren-
kiel et al., 2007; Petreanu et al., 2007; H.
Wang et al., 2007; Zhang and Oertner,
2007). Second, an inhibitory member of
the microbial opsin family (Ehrlich et al.,
1984;Hegemann et al., 1985; Duschl et al.,
1988; Bamberg et al., 1993; Kalaidzidis et
al., 1998; Kolbe et al., 2000) was brought
to neurobiology; in work stimulated by
the finding that the all-trans retinal chro-
mophore required by microbial opsins
appears already present within mamma-
lian brains (Zhang et al., 2006), it was
found that neurons targeted to express the
light-activated chloride pump halorho-
dopsin from Natronomonas pharaonis
(NpHR) can be hyperpolarized and inhib-
ited from firing action potentials when ex-
posed to yellow light in intact tissue and
behaving animals (Zhang et al., 2007a);
because of the excitation wavelength dif-
ference, the two optical gates can be si-
multaneously used in the same cells even
in vivo (Zhang et al., 2007a) and may
modulate aspects of neural synchrony
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with high temporal precision (Han and
Boyden, 2007) (for review, see Zhang et
al., 2007b). Third, genetic targeting tools
have been developed for versatile use of
microbial opsins with existing resources
including cell type-specific promotor
fragments or Cre-LoxPmouse driver lines
suitable for a wide variety of neuroscience
investigations (Adamantidis et al., 2007;
Zhang et al., 2007a,c; described below).
Finally, integrated fiber-optic and solid-
state optical approaches have provided
the complementary technology to allow
specific cell types, even deep within the
brain, to be controlled in freely behaving
mammals (Adamantidis et al., 2007; Ara-
vanis et al., 2007) (for review, see Zhang et
al., 2007b).
What factors limit opsin efficacy? One
potential limitation is that for inverte-
brates like Caenorhabditis elegans and
Drosophila, the all-trans retinal must be
delivered, but this turns out to be straight-
forward to provide in food or in the envi-
ronment (Nagel et al., 2005; Schroll et al.,
2006; Zhang et al., 2007a). In general, suf-
ficient levels of functional expression
(which may depend on gene delivery
method, copy number, promoter
strength, and time after initiation of gene
expression) must be obtained to either
potentiate or inhibit spiking. However,
care must be taken not to express the
opsins at excessive levels, because overex-
pression of membrane proteins can lead
to toxicity and loss of membrane integrity
in a wide variety of systems. We and our
colleagues have generated healthy ChR2-
EYFP transgenic mice lines with expres-
sion throughout the brain using the Thy1
promoter; under these conditions, ChR2
can be used tomap synaptically connected
neurons in anesthetized mice and in slices
(Arenkiel et al., 2007; H. Wang et al.,
2007). We note that visualization of
NpHR-transduced neurons indicates that
intracellular halorhodopsin accumula-
tion is particularly pronounced (Zhang et
al., 2007a). Indeed, as we recently have ex-
plored the regime of very high levels of
expression (strong promoters and high
viral-vector multiplicity of infection or
high gene copy number) to determine up-
per bounds of effect sizes, we have seen
intracellular accumulation and even
membrane blebbing toxicity that can be
prevented by returning to lower, effec-
tive expression levels (Zhang et al.,
2007a); this first-generation solution
soon may be enhanced by second-
generation molecular modifications to
modulate membrane targeting. NpHR
is well tolerated at expression levels that
subserve its inhibitory function both in
behaving C. elegans and in intact mam-
malian brain tissue (Zhang et al., 2007a),
andNpHR can be introduced developmen-
tally or in adulthood at suitable titers (Fig.
1A) (Zhang et al., 2007a).
Putting opsins in their place: beyond
genetic targeting in networks
The rate-limiting step in using these tools
is now directing their activity to the spe-
cific locations where electrical control is
needed, by controlling either localization
Figure1. Targetingmodalities.A, Developmental targeting:NpHR-EYFP (green) andChR2-mCherry (red) expression in layers
2 and 3 of the mouse cortex via timed in utero electroporation (E16 surgery, P27 coronal slicing). A mixture of CMV::NpHR-EYFP
and CMV::ChR2-mCherry DNA (1g/l each) was pressure injected unilaterally into the ventricle and electroporated [5 50 ms
pulses, 1 Hz, 40 V (see also Petreanu et al., 2007)]. Shown are pictures of acute slices taken on a Leica (Bannockburn, IL) MZ16FA
stereomicroscope. B, Anterograde projection-based targeting: unilateral delivery of CaMKII::ChR2-mCherry lentivirus (1.5l,
10 9pfu/ml) to theadultmousedentatehilus/CA3 (left, and inset showingdifferential interference contrast image superposition)
results in axonal ChR2-mCherry expression in the contralateral hippocampus (middle),withnoexpression in thegranule cell layer
(GCL) on either side of the brain (right). Note contralateral ChR2-mCherry-positive axonal projections to the molecular
layer and subgranular zone. Optical stimulation with 15 ms pulses of blue light (HQ470 nm/40; Chroma, Brattleboro,
VT) of ChR2-positive axonal projections in acute slices from the contralateral hippocampus evoked inward synaptic
currents in ChR2-negative dentate granule cells. A Lambda DG-4 optical switch (Sutter Instruments, Novato, CA) and 300
W xenon lamp were used for light delivery. Two injection sites were used at the following coordinates: anteroposterior
(AP), 2 mm; mediolateral (ML), 1.5 mm; dorsoventral (DV), 2 mm; and AP, 3 mm; ML, 3 mm; DV, 3 mm. C,
Promoter-based targeting: ChR2-EYFP (green) was targeted to excitatory hippocampal neurons in culture via
CaMKII::ChR2-EYFP lentivirus [infected 2 d in vitro (div)]; immunostaining for GAD67 (red; 1:250; Millipore, Billerica,
MA) in 14 div cultures shows exclusion of ChR2 expression from inhibitory GAD67 neurons. D, Subcellular targeting:
ChR2-EYFP (green) is expressed ubiquitously throughout the cell membrane in 16 div cultures. Adding the PDZ-domain
binding motif ETQV to the C terminus by in-frame cloning led to concentration of ChR2-EYFP at postsynaptic sites,
indicated by colocalization with PSD-95 staining (red; 1:200; Affinity Bioreagents, Golden, CO). Pearson’s correlation
(Manders et al., 1993) was r 0.78 for ChR2-EYFP-ETQV and r 0.40 for untargeted ChR2-EYFP; unpaired t test, ***p
0.0001; n 22 and 24 dendrites, respectively. Single confocal sections through 50m segments of proximal dendrites
were thresholded and correlation coefficients determined using Volocity software.
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of the light or localization of protein ex-
pression (e.g., via cell type-specific pro-
moters like the excitatory neuron-specific
CaMKII promoter) (Fig. 1C) (Aravanis
et al., 2007). To rapidly capitalize on the
many available mouse lines driving (for
example) Cre recombinase under the
control of cell type-specific promoters,
AAV vectors have been developed (Zhang
et al., 2007c) carrying microbial opsins
driven by a strong promoter followed by a
floxed-stop sequence that can be injected
into Cre-expressing mice. The cell type of
interest efficiently recombines the stop se-
quence out of the genome and allow opsin
expression under the strong promoter;
the cell type of interest is then susceptible
to control by fiber-optic light delivery reg-
istered to the virus injection sites using
published methods for reliably achieving
this crucial coregistration (Adamantidis
et al., 2007; Aravanis et al., 2007). These
promoter-based approaches are well
suited to distinguish the roles played by
specific neural types in the physiological
or pathological functioning of the ner-
vous system.
A potential limitation is that specific
promoter-based targeting strategies or
mouse Cre lines are not always immedi-
ately available or suitable for some exper-
iments. However, in many cases, projec-
tion patterns can be used to achieve
optical control over the desired neurons.
Contralateral projections in the brain
have been targeted by labeling cortical
neurons in vivo with ChR2, followed by
high-speed circuit mapping with light ex-
posure delivered to brain slices from the
contralateral hemisphere (Petreanu et al.,
2007). In this experiment, contralateral
axonal projections showed similar target
preference in comparison with the ipsilat-
eral projections. These experiments illus-
trate a targeting principle thatmay be gen-
eralizable. For example, Figure 1B shows
selective labeling of hippocampal con-
tralateral projections, in which axons of
ChR2-positive hippocampal cells from
the virus-injected hemisphere synapse
onto ChR2-negative granule cells in the
contralateral dentate gyrus. Optical stim-
ulation with blue light of the ChR2-
positive axonal projections contralateral
to the site of injection can activate
postsynaptic ChR2-negative dentate
granule cells (Fig. 1B, right). In this way
the selective impact of fibers traveling
from one brain region to another, spa-
tially separated, brain target region can be
studied simply by illuminating the target
brain region, a principle that could extend
to many other circuits (e.g., corticotha-
lamic and nigrostriatal projections) and
to species in which promoters are less well
defined (e.g., primates). However, a limi-
tation of this method is that in some cases
insufficient opsin accumulation in the
presynaptic terminal may prevent robust
spiking responses, which may be over-
come with molecular targeting strategies.
Another non-promoter-based targeting
method would be to use transsynaptic vi-
ral methods to introduce opsins; for ex-
ample, transsynaptic tracers based on ra-
bies virus will spread only to directly
connected cells, thereby allowing tests of
the functional role of neurons one synapse
removed from the initially infected cells
(Wickersham et al., 2007).
Cell types also can be targeted develop-
mentally. One example involves the tar-
geting of specific cortical layers with in
utero electroporation, as demonstrated
for ChR2 by Petreanu et al. (2007). In-
deed, in utero electroporation at precisely
timed embryonic days in mouse can be
used to target both ChR2 and NpHR to-
gether to individual cortical layers such as
layers II and III [embryonic day 15.5
(E15.5)] (Fig. 1A), layer IV (E13.5), or
layers V and VI (E12.5). In utero electro-
poration also could be used to express
ChR2/NpHR in the inhibitory neurons of
the striatum or in the hippocampus (Bor-
rell et al., 2005; Navarro-Quiroga et al.,
2007). A key advantage of in utero electro-
poration is that, unlike viral delivery
methods, there are no DNA size restric-
tions, which allows for expression of
opsins under control of a wider array of
promoters. Promoter-based strategies
could also be used to target specific corti-
cal layers, because emerging knowledge of
layer-specific markers (Lein et al., 2007)
may lead to highly specific targeting strat-
egies, and layer V of cortex already has
been targeted by generating transgenic
mice expressing ChR2-EYFP under con-
trol of the Thy1 promoter (Arenkiel et al.,
2007; H. Wang et al., 2007). Of course,
these spatial targeting strategies could
be complemented with traditional
promoter-based strategies, for example,
with promoter fragments, BAC (bacterial
artificial chromosome) transgenics
(Heintz, 2001), Cre/ROSA26-loxP mice
(Srinivas et al., 2001), or Gal4-UAS en-
hancer expression systems (Perrimon,
1998). For example, a combined
developmental/promoter-based strategy
could allow selective targeting of excita-
tory (CaMKII-expressing) neurons only
in layer 2/3 of cortex.
ChR2 and NpHR are ubiquitously lo-
calized membrane proteins when heter-
ologously expressed, and full-field illumi-
nation will generate membrane potential
changes synchronously across the entire
cell. This pattern of activity modulation is
suitable for most classes of circuit-level
experiments in which neurons simply
need to be activated or inhibited in spe-
cific temporal patterns. However, subcel-
lular targeting of opsins could be used to
modulate activity in a localized manner
even with full-field flash illumination; for
example, dendritic targeting of ChR2
could preserve physiological information
flow from synapse to soma to axon for
studies of subcellular signaling (synapse-
to-nucleus signaling, dendritic integra-
tion rules, spike timing-dependent plas-
ticity, and other backpropagating action
potential effects). To achieve precise opti-
cal control within neurons, we have ex-
plored the use of intracellular targeting
motifs that can be attached to the opsin
nucleotide sequences. As one example of
this approach, we have attached the PDZ-
domain binding sequence ETQV, a motif
involved in NMDA receptor clustering at
postsynaptic sites, to the C terminus of
ChR2-EYFP (Zito et al., 1999; Guerrero et
al., 2005). When expressed in hippocam-
pal neurons, ChR2-EYFP-ETQV was in-
deed concentrated at the sites of postsyn-
aptic densities, as indicated by selective
colocalization with PSD-95, in contrast to
the nonselective localization of ChR2-
EYFP (Fig. 1D). The postsynaptically re-
cruited protein maintained its ability to
induce precisely timed depolarization and
action potential firing in hippocampal
neurons (data not shown). If this synaptic
targeting were combined with precise op-
tical guidance strategies, the causal role of
neural population codes, in which mem-
bers of the population are individual syn-
apses rather than individual neurons,
could be studied. Other targeting strate-
gies (for example, to presynaptic termi-
nals, to axon hillocks and nodes, or to in-
tracellular membranes) should also be
possible and will facilitate temporally pre-
cise studies of subcellular signaling events
as well as network-level optogenetic
experiments.
Integrating multimodal readout
technologies with optical control
The fully equipped neuroscience optical
toolbox would include not only ChR2/
NpHR optical control, but also multiple
reliable readout technologies for answer-
ing a broad range of experimental
questions, in vitro and in vivo. Indeed, si-
multaneous optical control and electro-
physiological recording of neuronal activ-
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ity in vivo, even with intraparenchymal
stimulation, is now possible with inte-
grated submillimeter scale fiber optics and
recording electrodes (Fig. 2A), comple-
menting the capabilities of surface illumi-
nation described by Arenkiel et al. (2007).
In this way, local-circuit responses can be
measured with temporal precision that
matches the millisecond-scale precision
of ChR2/NpHR-based optical control,
even within deep brain structures in vivo.
This rapid feedback not only is experi-
mentally valuable, but also could be im-
portant for eventual clinical applications
of optical stimulation, so that therapeutic
stimulation parameters could be rapidly
tuned or timed in patients. A major limi-
tation in functional neurosurgery and in-
terventional psychiatry is the fact that
electrical artifacts from stimulating elec-
trodes prevent precisely simultaneous re-
cording from local neurons, so that it is
not clear whether particular brain stimu-
lation paradigms are activating, inhibit-
ing, or desynchronizing the target tissue.
Although care must still be taken with re-
gard to potential artifacts from external
electronics, the combined optical stimula-
tion/electrical recording approach allows
high-temporal-precision electrical assess-
ment of local responses in the absence of
locally generated electrical artifacts, al-
lowing local evoked spikes to be directly
visualized (Fig. 2A). Electroencephalog-
raphy is another electrical readout well
suited for simultaneous use with optoge-
netic stimulation (Adamantidis et al.,
2007).
However, for some applications, slow
or stable readouts are preferable. Slower
biochemical markers may be ideal for
tracking and validating the outcome of
optical neural control, particularly in
cases in which simultaneous imaging of
controlled cells is not possible but it is still
important to quantify the effect of optical
control on the stimulated or downstream
population. Activation of immediate-
early genes like c-fos and Arc can be mea-
sured with biochemicalmethods (e.g., an-
tibodies or GFP-based reporters) 60 min
or more after the presumptive optical
stimulation, and other transcription fac-
tor activation events (e.g., CREB Ser133
phosphorylation) provide sensitive assays
that can detect and stably report changes
in membrane potential (Fig. 2B). Blue
light exposure (470 nm for 10 min at 10
Hz/25 ms) to ChR2-expressing neurons
robustly elevated Ser133 pCREB levels
(Fig. 2B); in this way, changes in network
activity can be tracked using biochemical
traces, even after conclusion of optical
control of neural activity, although this
method is not precise enough for report-
ing the firing frequency experienced by
any one cell during the stimulation proto-
col. Even in the presence of synaptic activ-
ity blockers, optical activation of NpHR
(590 nm for 10 min) sufficed to signifi-
cantly lower Ser133 pCREB levels com-
pared with sham-treated neurons (Fig.
2B, inset); however, if the conditions are
not strong enough to separate two popu-
lations, the biochemical trace imaging
technique is not suitable for precisely de-
termining the fraction of cells controlled
by the optical protocol.
Fast optical readouts are needed as
well. The action spectra of ChR2 and
NpHR are such that even with single-
photon imaging, both tools can be used
simultaneously together with the fluores-
cent calcium indicator fura-2 (Fig. 2C)
(Zhang et al., 2007a), and each are also
compatible in principle with several or-
ganic voltage-sensitive dye strategies
(Zhang et al., 2006), e.g., the absorbance
dye RH-155 for slice physiology (Airan et
al., 2007).Moreover, the availability of ge-
netically encoded biosensors that can de-
tect glutamate levels, membrane voltage,
protein synthesis, or intracellular calcium
in vitro and in vivo (Reiff et al., 2005; Par-
rish et al., 2006; Garaschuk et al., 2007;
Heim et al., 2007) could provide cell type-
specific optical readouts for effects of cell
type-specific optical control with ChR2/
NpHR. A wide range of genetically tar-
getable activity reporters, such as
GCaMPs, pericams, or Camgaroos (Nagai
et al., 2001; Nakai et al., 2001; Kotlikoff,
2007), could be used together with ChR2/
NpHR in vitro and in vivo, but care must
be taken in choosing and/or developing
the right reporters whose excitation spec-
tra will not overlap with the ChR2/NpHR
action spectra. Moreover, the fast tropo-
nin C fluorescent resonance energy
transfer-based biosensor TN-XL (Mank
et al., 2006) is excited at 430 nm and could
be a good candidate for pairing with
NpHR. The availability of two-photon ex-
citation laser-scanningmicroscopy (Pettit
et al., 1997; Svoboda and Yasuda, 2006)
relaxes the need for nonoverlapping spec-
tra, and optical techniques including use
of multiple excitation spots, defocused
beams, and fast scanning over cells may
overcome the fact that two-photon mi-
crostimulation will only affect a small
number of opsins in a typical excitation
volume. Conversely, conventional two-
photon imaging of circuit responses could
be conducted in parallel with single-
photon excitation of large numbers of tar-
geted opsins. Finally, systems imaging
modalities like functional magnetic reso-
nance imaging and positron emission to-
mography will provide compatible in vivo
imaging readouts for optogenetic stimu-
lation experiments.
A key readout for systems
neuroscience-level questions is behavior
of freely moving animals. NpHR and
ChR2 have been used in combination to
control movement in freely moving C. el-
egans (Zhang et al., 2007a), and ChR2 has
been used tomodulate sleep–wake behav-
ior in mice (Adamantidis et al., 2007);
here, optical control of locomotion in
freely behaving adult mice expressing
ChR2 in cortical layer 5 is demonstrated
with fiber-optic/laser diode tools (Fig.
2D). Time locked to optical stimulation
onset and termination, rightmotor cortex
(area M2)-implanted animals displayed
an evoked bias for moving to the left side,
a behavior not seen in control (non-
ChR2-expressing) mice (Fig. 2D; see sup-
plemental movies for experimental and
control animals, available at www.
jneurosci.org as supplemental material).
The lightweight and thin optical fiber al-
lows unrestricted behavior of the subject
over long distances, and a commutator al-
lows even behavior involving rotation to
occur, an important feature for some dis-
ease models like Parkinson’s. In cases in
which the targeted cells or their dendrites
are superficial, cortical-surface light-
emitting diode (LED) illumination
through a cortical window and even
through thinned skull (Yoder and Klein-
feld, 2002) can also be used to drive tem-
porally precise motor output patterns
(Fig. 2E). Light-induced whisker deflec-
tions in these intact animals were mea-
suredmagnetically (Aravanis et al., 2007),
and in control experiments blue light illu-
mination in ChR2-negative mice had no
effect.
Summary
Interesting integrated applications of
these targeting and readout methods
could go beyond simply driving specific
populations of cells to driving specific
cells in different brain regions (e.g.,
among thalamus, cortex, hippocampus,
and striatum) with precise relative timing
(synchrony or asynchrony with well de-
fined phase shifts). For example, the mo-
tor behavioral studies (Fig. 2D) suggest
that specific cortical layers in a region
could be turned on or off with high tem-
poral precision in behaving subjects,
a possibility unapproachable with
electrode-based, pharmacological, or ge-
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Figure 2. Readoutmodalities in vitro and in vivo.A, Electrophysiology in vivo: simultaneous optical stimulation and electrical recording from cortex in an intact Thy1::ChR2-EYFPmouse using an
extracellular tungstenelectrode (1M,125mouterdiameter) glued toanoptical fiber (200mouterdiameter; ThorLabs,Newton,NJ); the0.5mmoffset (top right) ensures illumination
of recorded neurons. The top-right illumination cone picture was generated by placing the electrode and fiber ensemble into a 1-cm-thick block of 1% agar (electrode superficial as shown); the
geometrical dispersion is greatlymodulated by scattering in brain tissue as described previously (Aravanis et al., 2007). FC/PC-coupled fiber optic is shown (middle) coupled to a 473 nm laser diode
from CrystaLaser (Reno, NV) through an FC/PC adapter. Thy1::ChR2-EYFP (line 18) mice (Arenkiel et al., 2007; H. Wang et al., 2007) have strong ChR2 expression in layer 5 of neocortex (left).
Recordings in anesthetized mice showed reliable cortex activation with pulsed blue light (10 Hz/25 ms), without stimulation artifacts at either the onset or offset of the stimulus. pClamp 10 and
Digidata 1322A board (Molecular Devices, Union City, CA) were used to collect data and generate pulsed light. The recorded signal was bandpass filtered at 300 Hz low/5 kHz high (1800
Microelectrode AC Amplifier, A-M Systems, Sequim, WA). B, Post hoc biochemical imaging modality. Cultured hippocampal neurons [13–14 d in vitro (div), transduced 2 div with ChR2-EYFP and
NpHR-EYFP lentivirusesunder theCaMKIIpromoter)werepreincubated2hwith D-AP5 (25M) andNBQX (10M) and then stimulatedwith light in the continuedpresenceof D-AP5/NBQX.Blue
light delivery (HQ470 nm/40; Chroma) for 10 min at 10 Hz/25 ms to ChR2-expressing neurons significantly elevated Ser133 pCREB compared with sham-treated neurons (unpaired t test, p
0.0001;n60and72 cells, respectively). Inset, ActivationofNpHRwith10minof continuous amber light (593nm/20; Semrock, Rochester, NY) significantly loweredpCREB levels comparedwith
sham-treated neurons (unpaired t test, p 0.0001;n 80 and75 cells, respectively). Cumulative probability histograms shownuclear pCREB intensity normalized to the shamconditionmean. For
quantification of pCREB immunofluorescence (1:500;Millipore), five confocal images [40/1.3 numerical aperture (NA) oil]were acquired per stimulated region. Single optical sections through the
nucleuswere analyzedusingVolocity software, andnuclear regionswere definedbyDAPI labeling. Imaging andquantificationwere conductedblind to treatment condition. Optical stimulationwas
conducted on an Olympus (Tokyo, Japan) IX71 inverted scope using a 20/0.75 NA objective [7 mW/mm2 light intensity measured with Newport (Irvine, CA) 1815-C power meter]. C, Real-time
activity imaging modality. ChR2 and NpHR action spectra are shown superimposed with fura-2–Ca 2 indicator excitation spectrum and RH-155 voltage indicator absorption band. Spectral
separation allows for simultaneous all-optical control and readout.D, Directional control ofmammalian locomotionwith fiber-optic light delivery in freelymoving animals. Blue light stimulation of
the right secondary motor cortex (M2) in Thy1::ChR2-EYFP adult mice induced repetitive rotations to the left that terminated immediately with conclusion of optical stimulation (1.96
0.24 rotations/10 s). Light was delivered from the 473 nm laser via optical fiber through a fiber guide cannula (Plastics One, Roanoke, VA) targeted to the following coordinates:
anteroposterior, 1 mm; mediolateral, 0.5 mm; dorsoventral,0.5 mm. Pulses (30 Hz/15 ms) were generated using a function generator (33220A; Agilent, Palo Alto, CA). Cranioplastic
cement was used to stabilize the fiber guide, and a dummy cannula (a) was placed while animals were not being tested. To ensure stability of the fiber during testing in moving animals,
an internal cannula adapter (b) was glued to the stripped optical fiber (c), which was inserted into the fiber guide cannula fixed to the skull (d) (see also Adamantidis et al., 2007). A
custom aluminum rotating optical commutator (bottom; Doric Lenses, Que´bec, Canada) was used to release torsion in the fiber caused by the animal’s rotation. E, Whisking control with
LEDs in sedated Thy1::ChR2-EYFP animals. Optical excitation of vibrissal motor cortex was performed either through a small craniotomy (top traces) or through thinned skull (bottom
trace) with a blue LED [LEDtronics, Torrance, CA; skull thinned80% with standard drill as in Yoder and Kleinfeld (2002)]. Whisker deflections were measured as before (Aravanis et al.,
2007); a 1 mg rare-earth magnetic particle (Magcraft, Vienna, VA) was attached to the vibrissa, and a magnetoresistive sensor (Honeywell, Morristown, NJ) was used to measure
deflections.
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netic methods. These experiments are
within reach now, but there are also many
refinements of microbial opsin technol-
ogy still pending that could enhance the
power of the approach. For example, the
independence (in mammals) from exoge-
nous cofactors is a positive aspect, but it
remains possible that some mammalian
cellswill nothave sufficient retinoids to fully
support opsin function; in these cases, coin-
troduction of enzymes governing rate-
limiting steps in retinoiduptake andmetab-
olism (T. Wang et al., 2007; Yang and
O’Tousa, 2007) (Tracey, personal commu-
nication) might be helpful in driving maxi-
mally efficacious opsin function.
The subcellular-targeting approach
(Fig. 1D) suggests additional strategies to
target axons, somata, and synaptic termi-
nals. Other molecular modifications may
result in usefully shifted spectral proper-
ties [e.g. redshifted opsins for better tissue
penetration andmulticolor optical activa-
tion experiments (Luecke et al., 2001; Shi-
mono et al., 2003)], greater or lesser Ca2
permeance, or improved conductance
properties (Nagel et al., 2005). We find in
hippocampal neurons that H134R muta-
tion in ChR2 expressed under the synap-
sin I promoter gives rise to a 2.37 0.07-
( p  0.005) fold enhancement in steady
state current and 1.73 0.10 (p 0.005)
fold enhancement in peak current (n 5;
comparison with wild-type ChR2). It is
important to remember that in principle,
ChR2 and NpHR will contribute to small,
brief, and reversible elevations in intracel-
lular Ca2 andCl, respectively; likewise,
native excitatory transmission also ele-
vates intracellular Ca2 via Ca2-
permeable glutamate receptors and voltage-
activated Ca2 channels, and native
inhibitory transmission typically also ele-
vates intracellular Cl. Because elevations
in Ca2 can drive intracellular biochemical
changes, and elevations in Cl can modu-
late the effects of endogenous GABAergic
neurotransmission, these factors should be
considered in experimental design.
Findings obtained from microbial op-
sin work in animalmodels may ultimately
inform novel clinical approaches, even
without introduction of opsins into pa-
tients. Clinically compatible, noninvasive
interventions that are likely to modulate
neural activity, including radiation, ultra-
sound, and magnetic methods, all can be
depth targeted in various ways (for exam-
ple by using stereotactically guided
accumulation of energy at subcentimeter
resolution, delivered frommultiple calcu-
lated trajectories as with the radiation-
based CyberKnife/Gamma Knife, or
depth focused as with high-intensity fo-
cused ultrasound). Energy can be depth
targeted in other ways as well, for example
with fiber optics or implanted transducers
(Adamantidis et al., 2007). In principle,
many focusing methods could be used to
directly transduce energy, or even to acti-
vate custom stereotactically or endovas-
cularly delivered micro-“antennas” that
locally modulate radiation sensitivity, ul-
trasound response, and magnetic suscep-
tibility, at specific circuit nodes in the clin-
ical setting that had previously been
implicated with optogenetic animal mod-
els (Zhang et al., 2007b). However, work
in animal models will be a primary focus
of the field, and in itself can promote un-
derstanding of the circuit basis of neuro-
psychiatric diseases like narcolepsy (Ada-
mantidis et al., 2007).
Looking toward the future, plants and
many fungi and microbes are highly de-
pendent on light and therefore have de-
veloped highly specialized light-sensing
proteins that will likely continue to pro-
vide novel and powerful tools for perturb-
ing and interrogating the intact nervous
system. Optical activation of intracellular
signaling via modified opsins (Kim et al.,
2005) and blue-light-activated adenylate
cyclases (PACs) from the flagellate Eu-
glena gracilis (Iseki et al., 2002;Ntefidou et
al., 2003) can trigger rapid and reversible
increases in cAMP levels in vitro andmod-
ulate behavior in Drosophila in vivo
(Schroder-Lang et al., 2007). Pho-
totropins, photo-regulated protein ki-
nases (Huala et al., 1997; Briggs et al.,
2001), might also provide useful tools for
biochemistry studies of phosphorylation
events within a cell that could comple-
ment ChR2/NpHR modulation of bio-
chemical signaling, alongwith other light-
activated compounds yet to be identified.
Perhaps only a small fraction of the poten-
tial opsins and other tools identified in
macrogenetic approaches (e.g., Venter et
al., 2004) will be immediately useful, as
the experiencewith the comparatively un-
stable Halobacterium salinarum halorho-
dopsin (HsHR) revealed (Zhang et al.,
2007a), and the broad action spectra of
these naturally occurring proteins may
limit the number of independently ad-
dressable optical control channels achiev-
able, but identification of newplayersmay
refine the microbial opsin approach, and
molecular optimizations have the poten-
tial to incrementally further unlock latent
utility. Together, these novel tools, target-
ing techniques, and readout technologies
will extend the utility of the microbial
opsins in bidirectional, reversible, and
spatiotemporally precise control of activ-
ity in targeted neurons.
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